Related Experiment Video
Updated: Aug 11, 2026

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
Published on: October 22, 2012
Peptide specificities of myelin basic protein-reactive human T-cell clones
J R Richert1, C A Reuben-Burnside, G E Deibler
1Department of Neurology, Georgetown University Medical Center, Washington, DC 20007.
Researchers identified key areas on myelin basic protein (BP) recognized by T-cells in multiple sclerosis patients. These findings aid in understanding T-cell responses and developing new therapies for this autoimmune disease.
Area of Science:
- Neuroimmunology
- Molecular Immunology
Background:
- Multiple sclerosis (MS) is an autoimmune disease targeting the central nervous system.
- Myelin basic protein (BP) is a key autoantigen implicated in MS pathogenesis.
- Understanding T-cell recognition sites on BP is crucial for developing targeted therapies.
Purpose of the Study:
- To identify specific human T-cell recognition sites on the myelin basic protein (BP) molecule.
- To characterize the reactivity profile of T-cell clones derived from an MS patient.
- To investigate potential cross-reactivity with viral antigens.
Main Methods:
- Isolation and characterization of forty myelin basic protein (BP)-reactive T-cell clones from a multiple sclerosis patient.
- Epitope mapping to determine T-cell recognition sites on the BP molecule.
- Assessment of cross-reactivity with measles virus antigens.
Main Results:
- Identification of at least three distinct T-cell recognition sites on the BP molecule: N-terminal (residues 1-97), C-terminal (residues 98-170), and spanning residues 97-98.
- Demonstrated a marked preference of the isolated T-cell clones for the C-terminal half of the BP molecule.
- No cross-reactivity was observed between the BP-reactive T-cell clones and measles virus.
Conclusions:
- The study successfully delineated key human T-cell recognition sites on myelin basic protein (BP).
- The identified T-cell clones and recognition sites provide valuable tools for further research into MS pathogenesis.
- These findings support the potential for developing anticlonotypic monoclonal antibodies for therapeutic interventions in MS.
More Related Videos
10:47Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
Published on: October 27, 2016
08:09Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017